Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

The vaccine, manufactured by US pharmaceutical giant Moderna, was found to slash the risk of severe illness from respiratory ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

The latest actions by federal health authorities overseen by Robert F. Kennedy Jr. on vaccine development and evaluation are ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.